Alnylam Pharmaceuticals, Inc. (ALNY) CEO John Maraganore on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/01/19
Medical Stocks Blistered On Sanders Proposal — Is This A Correction?Investors Business Daily • 04/18/19
Alnlyam's Positive Phase 3 Results For Givosiran Pushes It Forward For Regulatory FilingsSeeking Alpha • 04/18/19